Gene · 667
Papers2,071
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
701 to 720 of 2,071
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| GSEA-assisted gene signatures valid for combinations of prognostic markers in PCNSL. | Sci Rep | 2020 | 32439996 | PubTator, text mining | PubMed |
| Tracing the Evolutionary Origin of Desmosomes. | Curr Biol | 2020 | 32428495 | PubTator, text mining | PubMed |
| A New Quantitative Cell-Based Assay Reveals Unexpected Microtubule Stabilizing Activity of Certain Kinase Inhibitors, Clinically Approved or in the Process of Approval. | Front Pharmacol | 2020 | 32425788 | PubTator, text mining | PubMed |
| G3BP1-linked mRNA partitioning supports selective protein synthesis in response to oxidative stress. | Nucleic Acids Res | 2020 | 32406909 | PubTator, text mining | PubMed |
| miR-1291 Functions as a Potential Serum Biomarker for Bullous Pemphigoid. | Dis Markers | 2020 | 32399091 | PubTator, text mining | PubMed |
| Bullous pemphigoid secondary to pembrolizumab mimicking toxic epidermal necrolysis. | JAAD Case Rep | 2020 | 32382629 | PubTator, text mining | PubMed |
| The tapeworm interactome: inferring confidence scored protein-protein interactions from the proteome of Hymenolepis microstoma. | BMC Genomics | 2020 | 32380953 | PubTator, text mining | PubMed |
| The association between clinical and laboratory findings of bullous pemphigoid and dipeptidyl peptidase-4 inhibitors in the elderly: a retrospective study. | Croat Med J | 2020 | 32378375 | PubTator, text mining | PubMed |
| Oncogenic states dictate the prognostic and predictive connotations of intratumoral immune response. | J Immunother Cancer | 2020 | 32376723 | PubTator, text mining | PubMed |
| Identification of developmental disorders including autism spectrum disorder using salivary miRNAs in children from Bosnia and Herzegovina. | PLoS One | 2020 | 32353026 | PubTator, text mining | PubMed |
| Detection of circulating anti-skin antibodies by indirect immunofluorescence and by ELISA: a comparative systematic review and meta-analysis. | Clin Chem Lab Med | 2020 | 32335537 | PubTator, text mining | PubMed |
| Nikolsky's sign: A pathognomic boon. | J Family Med Prim Care | 2020 | 32318376 | PubTator, text mining | PubMed |
| Capivasertib, an AKT Kinase Inhibitor, as Monotherapy or in Combination with Fulvestrant in Patients with AKT1 E17K-Mutant, ER-Positive Metastatic Breast Cancer. | Clin Cancer Res | 2020 | 32312891 | PubTator, text mining | PubMed |
| Integrated analysis and network pharmacology approaches to explore key genes of Xingnaojing for treatment of Alzheimer's disease. | Brain Behav | 2020 | 32304290 | PubTator, text mining | PubMed |
| Constitutionally High Serotonin Tone Favors Obesity: Study on Rat Sublines With Altered Serotonin Homeostasis. | Front Neurosci | 2020 | 32269507 | PubTator, text mining | PubMed |
| The Role of Collagen XVII in Cancer: Squamous Cell Carcinoma and Beyond. | Front Oncol | 2020 | 32266137 | PubTator, text mining | PubMed |
| Serum Levels of Interleukin 18 and Interleukin 10 in Iranian Patients with Bullous Pemphigoid and Their Correlation with BP180-NC16a and BP230. | Iran J Allergy Asthma Immunol | 2020 | 32245316 | PubTator, text mining | PubMed |
| Subtype-specific gout susceptibility loci and enrichment of selection pressure on ABCG2 and ALDH2 identified by subtype genome-wide meta-analyses of clinically defined gout patients. | Ann Rheum Dis | 2020 | 32238385 | PubTator, text mining | PubMed |
| Understanding the genetic basis of congenital insensitivity to pain. | Br Med Bull | 2020 | 32219415 | PubTator, text mining | PubMed |
| The Paradox of Cancer Immune Exclusion: Immune Oncology Next Frontier. | Cancer Treat Res | 2020 | 32215870 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/667/papers?page=36